DZP recognised in Rzeczpospolita’s 23rd Ranking of Law Firms
News | 25.06.2025
DZP took first place in four areas of law, with Daniel Chojnacki, head of the environmental protection team, once again receiving an individual award.
The Life Sciences Practice is composed of 30 specialists experienced in pharmaceutical and biotechnology law, food law, anti-monopoly law, healthcare and constitutional law.
We advise Polish and foreign entities in the pharmaceutical, healthcare, food and chemical sectors.
We specialise in strategic advice in the areas of reimbursement, distribution and telemedicine solutions.
Our clients are local government authorities, which we advise on the restructuring of the healthcare system.
We cooperate with sector organisations in consultation over legislative bills, preparing, e.g. opinions on whether bills comply with the Constitution and international law; we also participate in drawing up such regulations.
Our awareness of market practice enables us to render advice that gives a high level of legal safety and that is also effective in business terms. Where legal risks are identified, we try to propose solutions that will not only mitigate these risks but also achieve goals as near as possible to the client’s original intentions.
We run a legal blog where we regularly comment on legal changes affecting our clients' activity.
related articles
News | 25.06.2025
DZP took first place in four areas of law, with Daniel Chojnacki, head of the environmental protection team, once again receiving an individual award.
News | 17.04.2025
Our law firm has been nominated in the “Poland Firm of the Year” category by the prestigious publication recognizing companies and lawyers practicing in the life Sciences industry.
News | 26.03.2025
In the latest ranking published by Legal 500, 18 DZP experts were highlighted as leading lawyers, and as many as 10 new lawyers were recognized by this prestigious ranking.
Event | 24.03.2025
Mateusz Mądry, Marek Paluch, and Maciej Zajda will participate in the conference organized by the Massachusetts Institute of Technology, which will be held in Poland for the first time.
News | 20.03.2025
In the latest Chambers & Partners publication, as many as 20 DZP experts received individual recommendations. Our teams were recognized in 13 categories.
News | 12.03.2025
Our experts have prepared a report summarizing the key issues discussed at the DZP conference on upcoming regulatory changes and challenges in the pharmaceutical industry.